Clinical Trial Update: Anthocyanin Intake on Cardiometabolic Biomarkers [NA]

View source ↗

Summary

A completed clinical trial evaluating the impact of anthocyanin intake on cardiometabolic biomarkers in individuals with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Anthocyanin (anthocyanin)

Snippet

Sponsor: Shahid Beheshti University | Conditions: Coronary Artery Stenosis | NA | Status: COMPLETED